The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Elenkov, I. J., Wilder, R. L., Chrousos, G. P., & Vizi, E. S. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01470-4 · Cited by 2,252
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
A Meta-Analysis of Cytokines in Alzheimer's Disease
Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.012 · Cited by 1,108
Sarma, J. V., & Ward, P. A. (2011) · Cell and Tissue Research · doi:10.1007/s00441-010-1034-0 · Cited by 974
Biological Roles of Fibroblast Growth Factor-2*
Bikfalvi, A., Klein, S., Pintucci, G., & Rifkin, D. B. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0292 · Cited by 959
Microglial Activation and its Implications in the Brain Diseases
Thameem Dheen, S., Kaur, C., & Ling, E.-A. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707780597961 · Cited by 952
El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915
A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
Rubio-Perez, J. M., & Morillas-Ruiz, J. M. (2012) · The Scientific World Journal · doi:10.1100/2012/756357 · Cited by 839
ELAM-1 is an adhesion molecule for skin-homing T cells
Picker, L. J., Kishimoto, T. K., Smith, C. W., Warnock, R. A., & Butcher, E. C. (1991) · Nature · doi:10.1038/349796a0 · Cited by 826
Regulation of learning and memory by meningeal immunity: a key role for IL-4
Derecki, N. C., Cardani, A. N., Yang, C. H., Quinnies, K. M., Crihfield, A., Lynch, K. R., & Kipnis, J. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091419 · Cited by 800
Shields, M., & Lonergan Institute at Boston College (2001) · Method · doi:10.5840/method20011916 · Cited by 748
Neopterin as a Marker for Immune System Activation
Murr, C., Widner, B., Wirleitner, B., & Fuchs, D. (2002) · Current Drug Metabolism · doi:10.2174/1389200024605082 · Cited by 738
CXCR4–SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion
Kucia, M., Jankowski, K., Reca, R., Wysoczynski, M., Bandura, L., Allendorf, D. J., Zhang, J., Ratajczak, J., & Ratajczak, M. Z. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032355.66152.b8 · Cited by 698
Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimers Disease
Agostinho, P., A. Cunha, R., & Oliveira, C. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793176572 · Cited by 685
Barger, S. W., Hörster, D., Furukawa, K., Goodman, Y., Krieglstein, J., & Mattson, M. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9328 · Cited by 631
Anti-inflammatory activity of natural dietary flavonoids
Pan, M.-H., Lai, C.-S., & Ho, C.-T. (2010) · Food & Function · doi:10.1039/c0fo00103a · Cited by 605
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Cai, Z., Hussain, M. D., & Yan, L.-J. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.833510 · Cited by 583
Wolpe, S. D., Davatelis, G., Sherry, B., Beutler, B., Hesse, D. G., Nguyen, H. T., Moldawer, L. L., Nathan, C. F., Lowry, S. F., & Cerami, A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.2.570 · Cited by 571
Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease
Fuhrmann, M., Bittner, T., Jung, C. K. E., Burgold, S., Page, R. M., Mitteregger, G., Haass, C., LaFerla, F. M., Kretzschmar, H., & Herms, J. (2010) · Nature Neuroscience · doi:10.1038/nn.2511 · Cited by 562
Varfolomeev, E. E., & Ashkenazi, A. (2004) · Cell · doi:10.1016/s0092-8674(04)00166-7 · Cited by 501
Elyaman, W., Bradshaw, E. M., Uyttenhove, C., Dardalhon, V., Awasthi, A., Imitola, J., Bettelli, E., Oukka, M., van Snick, J., Renauld, J.-C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812530106 · Cited by 498
Morales, I., Guzmán-MartÃnez, L., Cerda-Troncoso, C., FarÃas, G. A., & Maccioni, R. B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00112 · Cited by 490
Neuroinflammatory processes in Alzheimer’s disease
Heneka, M. T., O’Banion, M. K., Terwel, D., & Kummer, M. P. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0438-z · Cited by 433 · cited 2×
“It was also suggested that neurons might exacerbate local inflammatory reactions, resulting in their own destructions [16].”
Shaftel, S. S., Kyrkanides, S., Olschowka, J. A., Miller, J.-N. H., Johnson, R. E., & O’Banion, M. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31450 · Cited by 433 · cited 1×
“6 activity was increased in the AD brain [46].”
Grammas, P. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-26 · Cited by 432
Inflammatory process in Alzheimer's Disease
Meraz-Ríos, M. A., Toral-Rios, D., Franco-Bocanegra, D., Villeda-Hernández, J., & Campos-Peña, V. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00059 · Cited by 427
Microglia and Inflammation in Alzheimers Disease
Mandrekar-Colucci, S., & Landreth, G. E. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791012071 · Cited by 421
Impaired interleukin 12 production in human immunodeficiency virus-infected patients.
Chehimi, J., Starr, S. E., Frank, I., D'Andrea, A., Ma, X., MacGregor, R. R., Sennelier, J., & Trinchieri, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1361 · Cited by 419
Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia
Calabrese, V., Lodi, R., Tonon, C., D'Agata, V., Sapienza, M., Scapagnini, G., Mangiameli, A., Pennisi, G., Stella, A. M. G., & Butterfield, D. A. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.012 · Cited by 406
Altered Lipid Metabolism in Brain Injury and Disorders
Adibhatla, R. M., & Hatcher, J. F. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_9 · Cited by 401
Sobel, R. A., Mitchell, M. E., & Fondren, G. (1990) · Europe PMC (PubMed Central) · Cited by 388
Heeschen, C., Dimmeler, S., Hamm, C. W., Fichtlscherer, S., Boersma, E., Simoons, M. L., & Zeiher, A. M. (2003) · Circulation · doi:10.1161/01.cir.0000065232.57371.25 · Cited by 388
Biological role of lactoferrin
Sanchez, L., Calvo, M., & Brock, J. H. (1992) · Archives of Disease in Childhood · doi:10.1136/adc.67.5.657 · Cited by 378
Dinarello, C. A. (1999) · Methods · doi:10.1006/meth.1999.0837 · Cited by 369
Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology
Guillot-Sestier, M.-V., Doty, K. R., Gate, D., Rodriguez, J., Leung, B. P., Rezai-Zadeh, K., & Town, T. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.068 · Cited by 363
Cytokines and the central nervous system
Szelényi, J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00428-2 · Cited by 358
Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
Rojo, L. E., Fernández, J. A., Maccioni, A. A., Jimenez, J. M., & Maccioni, R. B. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.10.001 · Cited by 351
Cortes-Canteli, M., Paul, J., Norris, E. H., Bronstein, R., Ahn, H. J., Zamolodchikov, D., Bhuvanendran, S., Fenz, K. M., & Strickland, S. (2010) · Neuron · doi:10.1016/j.neuron.2010.05.014 · Cited by 339
Neurotrophic factors in Alzheimer’s disease: role of axonal transport
Schindowski, K., Belarbi, K., & Buée, L. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00378.x · Cited by 335
Tselepis, A. D., & John Chapman, M. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(02)00045-4 · Cited by 314
Martinez-Nunez, R. T., Louafi, F., & Sanchez-Elsner, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169367 · Cited by 308
The LPS receptor (CD14) links innate immunity with Alzheimer's disease
Fassbender, K., Walter, S., Kühl, S., Landmann, R., Ishii, K., Bertsch, T., Stalder, A. K., Muehlhauser, F., Liu, Y., Ulmer, A. J., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0364fje · Cited by 307
The role of TNF and its receptors in Alzheimer's disease
Perry, R. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00291-3 · Cited by 297
Xia, M., Qin, S., Wu, L., Mackay, C. R., & Hyman, B. T. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65542-3 · Cited by 292
The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ
Zheng, C., Zhou, X.-W., & Wang, J.-Z. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0054-4 · Cited by 292
Intrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease
Galimberti, D., Schoonenboom, N., Scheltens, P., Fenoglio, C., Bouwman, F., Venturelli, E., Guidi, I., Blankenstein, M. A., Bresolin, N., & Scarpini, E. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.538 · Cited by 289
London, A., Cohen, M., & Schwartz, M. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00034 · Cited by 282 · cited 1×
“Bone marrow derived macrophages can infiltrate the CNS under particular circumstances and contribute more efficiently in the elimination of amyloid deposits than microglia [26, 27, 28].”
Cruikshank, W. W., Kornfeld, H., & Center, D. M. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.6.757 · Cited by 279
Neuroinflammation in Alzheimer’s disease
Zhang, F., & Jiang, L. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75546 · Cited by 276
Jin, J.-J., Kim, H.-D., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-23 · Cited by 275
Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease
Mecocci, P., & Polidori, M. C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.006 · Cited by 270
Xia, M. Q., Bacskai, B. J., Knowles, R. B., Qin, S. X., & Hyman, B. T. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00285-x · Cited by 269
Söllvander, S., Nikitidou, E., Brolin, R., Söderberg, L., Sehlin, D., Lannfelt, L., & Erlandsson, A. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0098-z · Cited by 267
Biological markers for therapeutic trials in Alzheimer’s disease
Frank, R. A., Galasko, D., Hampel, H., Hardy, J., de Leon, M. J., Mehta, P. D., Rogers, J., Siemers, E., & Trojanowski, J. Q. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00002-2 · Cited by 252
Mig, the Monokine Induced By Interferon-γ, Promotes Tumor Necrosis In Vivo
Sgadari, C., Farber, J. M., Angiolillo, A. L., Liao, F., Teruya-Feldstein, J., Burd, P. R., Yao, L., Gupta, G., Kanegane, C., & Tosato, G. (1997) · Blood · doi:10.1182/blood.v89.8.2635 · Cited by 246
Szczepanik, A. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00404-5 · Cited by 243
Craig-Schapiro, R., Kuhn, M., Xiong, C., Pickering, E. H., Liu, J., Misko, T. P., Perrin, R. J., Bales, K. R., Soares, H., Fagan, A. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018850 · Cited by 237
Zhang, J., Ke, K.-F., Liu, Z., Qiu, Y.-H., & Peng, Y.-P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075786 · Cited by 233
Parajuli, B., Sonobe, Y., Horiuchi, H., Takeuchi, H., Mizuno, T., & Suzumura, A. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.503 · Cited by 232
The Role of Biomarkers in Clinical Trials for Alzheimer Disease
Thal, L. J., Kantarci, K., Reiman, E. M., Klunk, W. E., Weiner, M. W., Zetterberg, H., Galasko, D., Praticò, D., Griffin, S., Schenk, D., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000191420.61260.a8 · Cited by 232
Sutinen, E. M., Pirttilä, T., Anderson, G., Salminen, A., & Ojala, J. O. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-199 · Cited by 230
Proescholdt, M. A., Heiss, J. D., Walbridge, S., Mühlhauser, J., Capogrossi, M. C., Oldfield, E. H., & Merrill, M. J. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199906000-00006 · Cited by 226
Biomarkers of Oxidative Damage and Inflammation in Alzheimer's Disease
Galasko, D., & Montine, T. J. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.89 · Cited by 221
Boissonneault, V., Filali, M., Lessard, M., Relton, J., Wong, G., & Rivest, S. (2008) · Brain · doi:10.1093/brain/awn331 · Cited by 221
Interferon activation and innate immunity.
Page, C. L., Génin, P., Baines, M. G., & Hiscott, J. B. (2000) · PubMed · Cited by 211
Alzheimer's disease peptide β-amyloid interacts with fibrinogen and induces its oligomerization
Ahn, H. J., Zamolodchikov, D., Cortes-Canteli, M., Norris, E. H., Glickman, J. F., & Strickland, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010373107 · Cited by 209
Chakrabarty, P., Ceballos-Diaz, C., Beccard, A., Janus, C., Dickson, D., Golde, T. E., & Das, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903382 · Cited by 206
Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation
Regen, F., Hellmann-Regen, J., Costantini, E., & Reale, M. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666170203141717 · Cited by 204
Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases
Grammas, P., Martinez, J., & Miller, B. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001918 · Cited by 202
Diverse functional roles of lipocalin-2 in the central nervous system
Jha, M. K., Lee, S., Park, D. H., Kook, H., Park, K.-G., Lee, I.-K., & Suk, K. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.12.006 · Cited by 195
Self-citationSaresella, M., Calabrese, E., Marventano, I., Piancone, F., Gatti, A., Alberoni, M., Nemni, R., & Clerici, M. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.12.004 · Cited by 188
Christen, U., McGavern, D. B., Luster, A. D., von Herrath, M. G., & Oldstone, M. B. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6838 · Cited by 178
Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors.
(2014) · Europe PMC (PubMed Central) · Cited by 177
Prostaglandins and other lipid mediators in Alzheimer’s disease
Bazan, N. G., Colangelo, V., & Lukiw, W. J. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00031-x · Cited by 173
Zuliani, G., Cavalieri, M., Galvani, M., Passaro, A., Munari, M. R., Bosi, C., Zurlo, A., & Fellin, R. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.05.020 · Cited by 173
Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascade
Jacobsen, J. S., Comery, T. A., Martone, R. L., Elokdah, H. M., Crandall, D. L., Oganesian, A., Aschmies, S., Kirksey, Y. M., Gonzales, C., Xu, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710823105 · Cited by 172
Lactotransferrin immunocytochemistry in Alzheimer and normal human brain.
Kawamata, T., Tooyama, I., Yamada, T., Walker, D. G., & McGeer, P. L. (1993) · PubMed · Cited by 171
IL-17 Enhancement of the IL-6 Signaling Cascade in Astrocytes
Ma, X., Reynolds, S. L., Baker, B. J., Li, X., Benveniste, E. N., & Qin, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000142 · Cited by 171
Meda, L., Baron, P., Prat, E., Scarpini, E. A., Scarlato, G., Cassatella, M. A., & Rossi, F. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00188-x · Cited by 170
Imaging Microglial Activation During Neuroinflammation and Alzheimer’s Disease
Venneti, S., Wiley, C. A., & Kofler, J. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9142-2 · Cited by 170
IFN‐γ enhances neurogenesis in wild‐type mice and in a mouse model of Alzheimer's disease
Baron, R., Nemirovsky, A., Harpaz, I., Cohen, H., Owens, T., & Monsonego, A. (2008) · The FASEB Journal · doi:10.1096/fj.08-105866 · Cited by 166
Clearance of Amyloid-β Peptides By Microglia and Macrophages: the Issue of What, When and Where
Lai, A. Y., & McLaurin, J. (2012) · Future Neurology · doi:10.2217/fnl.12.6 · Cited by 162
RANTES upregulation in the Alzheimer's disease brain: A possible neuroprotective role
Tripathy, D., Thirumangalakudi, L., & Grammas, P. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.009 · Cited by 161
Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis
Lastres-Becker, I., Innamorato, N. G., Jaworski, T., Rábano, A., Kügler, S., Van Leuven, F., & Cuadrado, A. (2014) · Brain · doi:10.1093/brain/awt323 · Cited by 160
Antioxidant Therapy in Alzheimers Disease: Theory and Practice
Aliev, G., Obrenovich, M., Reddy, V., Shenk, J., Moreira, P., Nunomura, A., Zhu, X., Smith, M., & Perry, G. (2008) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955708786369582 · Cited by 159
Increased production of inflammatory cytokines in mild cognitive impairment
Magaki, S., Mueller, C., DICKSON, C., & Kirsch, W. M. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.09.015 · Cited by 157
Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer’s disease
Arosio, B., Trabattoni, D., Galimberti, L., Bucciarelli, P., Fasano, F. R., Calabresi, C., Cazzullo, C. L., Vergani, C., Annoni, G., & Clerici, M. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.10.009 · Cited by 156
Kiyota, T., Dixie, K. L. I., Jacobsen, M. T., Xiong, H., & Ikezu, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102349108 · Cited by 154
Bhaskar, K., Maphis, N. M., Xu, G., Varvel, N. H., Kokiko‐Cochran, O. N., Weick, J. P., Staugaitis, S. M., Cardona, A. E., Ransohoff, R. M., Herrup, K., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.007 · Cited by 153
CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer’s disease model
Krauthausen, M., Kummer, M. P., Zimmermann, J., Reyes-Irisarri, E., Terwel, D., Bulic, B., Heneka, M. T., & Müller, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci66771 · Cited by 153
Inflammatory markers in AD and MCI patients with different biomarker profiles
Schuitemaker, A., Dik, M. G., Veerhuis, R., Scheltens, P., Schoonenboom, N. S. M., Hack, C. E., Blankenstein, M. A., & Jonker, C. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.014 · Cited by 149
Lipocalin-2 as a therapeutic target for brain injury: an astrocentric perspective
Suk, K. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.08.001 · Cited by 145 · cited 1×
“(2011) previously showed increased plasma levels of LCN2 in patients with mild cognitive impairment [246,247,248].”
Self-citationType-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer’s disease
Taylor, J. M., Minter, M. R., Newman, A. G., Zhang, M., Adlard, P. A., & Crack, P. J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.089 · Cited by 145 · cited 2×
“neurotoxicity induced by A, which suggested that inhibiting the IFN receptors may be a an useful prevention strategies [90].”
Leyhe, T., Stransky, E., Eschweiler, G. W., Buchkremer, G., & Laske, C. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0764-9 · Cited by 145
IL-4-Induced Selective Clearance of Oligomeric β-Amyloid Peptide1–42 by Rat Primary Type 2 Microglia
Shimizu, E., Kawahara, K., Kajizono, M., Sawada, M., & Nakayama, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6503 · Cited by 143
The IL-17 Family Cytokines in Immunity and Disease
Pappu, R., Ramirez-Carrozzi, V. R., Ota, N., Ouyang, W., & Hu, Y. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9369-6 · Cited by 142
Buchhave, P., Zetterberg, H., Blennow, K., Minthon, L., Janciauskiene, S. M., & Hansson, O. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.10.012 · Cited by 140
Peripheral Cytokines and Chemokines in Alzheimer’s Disease
Lee, K. S., Chung, J. H., Choi, T.-K., Suh, S. Y., Oh, B. H., & Hong, C. H. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000245156 · Cited by 140
Modulation of inflammation in transgenic models of Alzheimer’s disease
Birch, A. M., Katsouri, L., & Sastre, M. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-25 · Cited by 139
Belkhelfa, M., Rafa, H., Medjeber, O., Arroul-Lammali, A., Behairi, N., Abada-Bendib, M., Makrelouf, M., Belarbi, S., Masmoudi, A. N., Tazir, M., et al. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2013.0085 · Cited by 138
Aliev, G., Priyadarshini, M., Reddy, V., Grieg, N. H., Kaminsky, Y., Cacabelos, R., Ashraf, G., Jabir, N. R., Kamal, M. A., Nikolenko, V. N., et al. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131227161303 · Cited by 138
Inflammation and Anti-Inflammatory Strategies for Alzheimer’s Disease – A Mini-Review
McNaull, B. B. A., Todd, S., McGuinness, B., & Passmore, A. P. (2009) · Gerontology · doi:10.1159/000237873 · Cited by 135
ApoE4 and Aβ Oligomers Reduce BDNF Expression via HDAC Nuclear Translocation
Sen, A., Nelson, T. J., & Alkon, D. L. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.0260-15.2015 · Cited by 133
Man, S., Ma, Y., Shang, D., Zhao, W., Li, B., Guo, D., Fang, W., Zhu, L., & Chen, Y. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.013 · Cited by 130
Increased plasma levels of lipocalin 2 in mild cognitive impairment
Choi, J., Lee, H., & Suk, K. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.023 · Cited by 128
Self-citationA deficiency in CCR2+ monocytes: the hidden side of Alzheimer’s disease
Naert, G., & Rivest, S. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt028 · Cited by 123
Tobinick, E. (2009) · CNS Drugs · doi:10.2165/11310810-000000000-00000 · Cited by 117
Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition
Chakrabarty, P., Tianbai, L., Herring, A., Ceballos-Diaz, C., Das, P., & Golde, T. E. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-36 · Cited by 116
Avila-Muñoz, E., & Arias, C. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.004 · Cited by 114
The role and therapeutic potential of monocytic cells in Alzheimer's disease
Malm, T., Koistinaho, M., Muona, A., Magga, J. M., & Koıstınaho, J. (2010) · Glia · doi:10.1002/glia.20973 · Cited by 113
Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia
Rosa, M. D., dell'Ombra, N., Zambito, A. M., Malaguarnera, M., Nicoletti, F., & Malaguarnera, L. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04780.x · Cited by 108
Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain
Selenica, M. B., Alvarez, J. A., Nash, K. R., Lee, D. C., Cao, C., Lin, X., Reid, P., Mouton, P. R., Morgan, D., & Gordon, M. N. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-86 · Cited by 108
Cheng, X., Yang, L., He, P., Li, R., & Shen, Y. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1253 · Cited by 106
Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease
Combrinck, M. I. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.063131 · Cited by 105
PECAM‐1, a key player in neuroinflammation
Kalinowska, A., & Losy, J. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01640.x · Cited by 103
The Long Pentraxin 3 and Its Role in Autoimmunity
Ortega‐Hernandez, O., Bassi, N., Shoenfeld, Y., & Anaya, J. (2008) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.03.006 · Cited by 103
Cytokines in Alzheimer's Disease and Vascular Dementia
Angelopoulos, P., Aggouridaki, H., Vaiopoulos, H., Siskou, E., Doutsou, K., Costa, V., & Balogiannis, S. (2008) · International Journal of Neuroscience · doi:10.1080/00207450701392068 · Cited by 102
Transforming growth factor beta in Alzheimer's disease
Chao, C. C., Hu, S., Frey, W. H., A, T., Tourtellotte, W. W., & Peterson, P. K. (1994) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.1.1.109-110.1994 · Cited by 102
Kiyota, T., Gendelman, H. E., Weir, R. A., Higgins, E. E., Zhang, G., & Jain, M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.08.009 · Cited by 100
Mastrangelo, M. A., Sudol, K. L., Narrow, W. C., & Bowers, W. J. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090059 · Cited by 100
Álvarez, R., Álvarez, V., Lahoz, C. H., Martinez, C., Pena, J., Sanchez, J. M., Guisasola, L. M., Salas‐Puig, J., Morís, G., Vidal, J. A. C., et al. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.6.733 · Cited by 98
Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease
Daborg, J., Andréasson, U., Pekna, M., Lautner, R., Hanse, E., Minthon, L., Blennow, K., Hansson, O., & Zetterberg, H. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0797-8 · Cited by 96
Wang, P., Wan, D.-H., Pang, L.-R., Gu, Z.-H., Qiu, W., Weng, S., Yu, X., & He, J. (2011) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2011.06.002 · Cited by 95
Chemokines and Alzheimer's disease
Streit, W., Conde, J. R., & Harrison, J. K. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00290-1 · Cited by 95
The Role of Macrophage Migration Inhibitory Factor in Alzheimer’s Disease
Bacher, M., Deuster, O., Aljabari, B., Egensperger, R., Neff, F., Jessen, F., Popp, J., Noelker, C., Reese, J. P., Al‐Abed, Y., et al. (2010) · Molecular Medicine · doi:10.2119/molmed.2009.00123 · Cited by 93
Interferon‐β Is a Potent Promoter of Nerve Growth Factor Production by Astrocytes
Boutros, T., Croze, E., & Yong, V. W. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69030939.x · Cited by 93
The vascular contribution to Alzheimer's disease
Altman, R., & Rutledge, J. C. (2010) · Clinical Science · doi:10.1042/cs20100094 · Cited by 93
The Potential Role of Chemokines in Alzheimer’s Disease Pathogenesis
Azizi, G., Hossein‐Khannazer, N., & Mirshafiey, A. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513518651 · Cited by 92
Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease
Calissano, P., Matrone, C., & Amadoro, G. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20759 · Cited by 92
Iademarco, M. F., McQuillan, J. J., & Dean, D. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3943 · Cited by 90
Franciosi, S., Choi, H. B., Kim, S. U., & McLarnon, J. G. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.10.006 · Cited by 89
Self-citationSerum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease
Angelis-Stoforidis, P., Scharf, S., Mander, A. G., Vajda, F. J. E., & Christophidis, N. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00136-0 · Cited by 88
Interferon-α Causes Neuronal Dysfunction in Encephalitis
Sas, A., Bimonte‐Nelson, H. A., Smothers, C. T., Woodward, J. J., & Tyor, W. R. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5595-08.2009 · Cited by 87
van Exel, E. R., Eikelenboom, P., Comijs, H. C., Frölich, M., Smit, J. H., Stek, M. L., Scheltens, P., Eefsting, J. E., & Westendorp, R. G. J. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.146 · Cited by 87
Pellicanò, M., Bulati, M., Buffa, S., Barbagallo, M., Di Prima, A., Misiano, G., Picone, P., Di Carlo, M., Nuzzo, D., Candore, G., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091714 · Cited by 86
Decreased Fractalkine and Increased IP-10 Expression in Aged Brain of APPswe Transgenic Mice
Duan, R., Yang, X., Chen, Z., Lu, M., Morris, C. M., Winblad, B. G., & Zhu, J. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9554-z · Cited by 86
Prakash, A., Medhi, B., & Chopra, K. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.05.015 · Cited by 86
Chambers, R. E., MacFarlane, D. G., Whicher, J. T., & Dieppe, P. A. (1983) · Annals of the Rheumatic Diseases · doi:10.1136/ard.42.6.665 · Cited by 85
Nagata, T., Kobayashi, N., Ishii, J., Shinagawa, S., Nakayama, R., Shibata, N., Kuerban, B., Ohnuma, T., Kondo, K., Arai, H., et al. (2015) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000375367 · Cited by 82
Inhibition of Alzheimer β-Peptide Fibril Formation by Serum Amyloid P Component
Janciauskiene, S. M., de Frutos, P. G., Carlemalm, E., Dahlbäck, B., & Eriksson, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26041 · Cited by 82
Migration of blood cells to β-amyloid plaques in Alzheimer's disease
Hohsfield, L. A., & Humpel, C. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.03.002 · Cited by 79 · cited 1×
“However, beside their beneficial effects, they could play a role in neural loss by overproduction of proinflammatory molecules and abnormal ROS production [29].”
Implication of Complement System and its Regulators in Alzheimers Disease
Kolev, M. V., Ruseva, M. M., Harris, C. L., Morgan, B. P., & Donev, R. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602805 · Cited by 78
Plasma Interleukin-10 Levels and Adverse Outcomes in Acute Coronary Syndrome
Çavuşoğlu, E., Marmur, J. D., Hojjati, M. R., Chopra, V., Butala, M., Subnani, R., Huda, M. S., Yanamadala, S., Ruwende, C., Eng, C., et al. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.02.040 · Cited by 77
Complement activation as a biomarker for Alzheimer's disease
Aiyaz, M., Lupton, M. K., Proitsi, P., Powell, J. F., & Lovestone, S. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.023 · Cited by 77
Neuropathology and the Neuroinflammation Idea
Mrak, R. E. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1158 · Cited by 75
Hsiao, H., Mak, O., Yang, C., Liu, Y., Fang, K., & Tzeng, S. (2006) · Glia · doi:10.1002/glia.20453 · Cited by 73
Hampel, H. J., Haslinger, A., Scheloske, M., Padberg, F., Fischer, P., Unger, J., Teipel, S. J., Neumann, M., Rosenberg, C., Oshida, R., et al. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0558-2 · Cited by 73
Triaca, V., Sposato, V., Bolasco, G., Ciotti, M. T., Pelicci, P., Bruni, A. C., Cupidi, C., Maletta, R., Feligioni, M., Nisticò, R., et al. (2016) · Aging Cell · doi:10.1111/acel.12473 · Cited by 73
Neurotrophins - From Pathophysiology to Treatment in Alzheimers Disease
Hellweg, R., Schulte‐Herbrüggen, O., & Jockers-Scherübl, M. C. (2008) · Current Alzheimer Research · doi:10.2174/156720508783884620 · Cited by 72
Zhu, M., Allard, J. S., Zhang, Y., Perez, E., Spangler, E. L., Becker, K. G., & Rapp, P. R. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000060 · Cited by 70
Rentzos, M., Paraskevas, G. P., Kapaki, E. N., Nikolaou, C., Zoga, M., Rombos, A., Tsoutsou, A., & Vassilopoulos, D. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.063 · Cited by 69
Joslin, G., Griffin, G. L., August, A. M., Adams, S. P., Fallon, R. J., Senior, R. M., & Perlmutter, D. H. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115934 · Cited by 68
Man, Sm, -, M., Yr, Shang, S., Zhao, Wd, Li, Guo, Fang, et al. (2006) · 中国生物学文摘 · Cited by 68
Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease
Yu, J., Tan, L., Song, J., Sun, Y., Chen, W., Miao, D., & Tian, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2008.11.083 · Cited by 67
Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component
Kolstoe, S. E., Ridha, B. H., Bellotti, V., Wang, N., Robinson, C. V., Crutch, S. J., Keir, G., Kukkastenvehmas, R. H., Gallimore, J. R., Hutchinson, W. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902640106 · Cited by 67
Gourmala, N. G., Limonta, S., Bochelen, D., Sauter, A., & Boddeke, H. W. G. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00295-4 · Cited by 66
Rentzos, M., Zoga, M., Paraskevas, G. P., Kapaki, E., Rombos, A., Nikolaou, C., Tsoutsou, A., & Vassilopoulos, D. (2006) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706286226 · Cited by 65
Laske, C., Stellos, K., Eschweiler, G. W., Leyhe, T., & Gawaz, M. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15107 · Cited by 62
Cognitive deterioration in Alzheimer’s disease is accompanied by increase of plasma neopterin
Blasko, I., Knaus, G., Weiss, E. M., Kemmler, G., Winkler, C., Falkensammer, G., Griesmacher, A., Würzner, R., Marksteiner, J., & Fuchs, D. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.02.001 · Cited by 62
PDGF is associated with neuronal and glial alterations of Alzheimer's disease
Masliah, E., Mallory, M., Alford, M., Deteresa, R., & Saitoh, T. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00050-o · Cited by 61
Serum Interleukin (IL)-15 as a Biomarker of Alzheimer's Disease
Bishnoi, R. J., Palmer, R. F., & Royall, D. R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117282 · Cited by 61
Katsouri, L., Ashraf, A., Birch, A. M., Lee, K. K. L., Mirzaei, N., & Sastre, M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.004 · Cited by 60
Peripheral inflammatory biomarkers of Alzheimer’s disease: the role of platelets
Casoli, T., Stefano, G. D., Balietti, M., Solazzi, M., Giorgetti, B., & Fattoretti, P. (2010) · Biogerontology · doi:10.1007/s10522-010-9281-8 · Cited by 60
Li, S.-Q., Yu, Y., Han, J.-Z., Wang, D., Liu, J., Qian, F., Fan, G.-H., Bucala, R., & Ye, R. D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0396-3 · Cited by 59
Olson, L., & Humpel, C. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.10.011 · Cited by 59
Colley, K. J., Wolfert, R. L., & Cobble, M. E. (2011) · The EPMA Journal · doi:10.1007/s13167-011-0063-4 · Cited by 58
Manczak, M., Mao, P., Nakamura, K., Bebbington, C., Park, B., & Reddy, P. H. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp331 · Cited by 56
A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects
Grimaldi, L. M. E., Zappalà, G., Iemolo, F., Castellano, A. E., Ruggieri, S. A., Bruno, G., & Paolillo, A. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-30 · Cited by 56
Bodmer, S., Podlisny, M. B., Selkoe, D. J., Heid, I., & Fontana, A. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91229-l · Cited by 55
Increased Serum Neopterin Concentrations in Patients with Alzheimer’s Disease
Leblhuber, F., Walli, J., Demel, U., Tilz, G. P., Widner, B., & Fuchs, D. (1999) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1999.070 · Cited by 55
Laske, C., Stellos, K., Stransky, E., Seizer, P., Akcay, Ö., Eschweiler, G. W., Leyhe, T., & Gawaz, M. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15311 · Cited by 54
Bioplex analysis of plasma cytokines in Alzheimer’s disease and mild cognitive impairment
Lee, K. S., Chung, J. H., Lee, K. H., Shin, M., Oh, B. H., & Hong, C. H. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.09.004 · Cited by 53
Soluble cell adhesion molecules in monocytes of Alzheimer’s disease and mild cognitive impairment
Hochstrasser, T., Weiss, E. M., Marksteiner, J., & Humpel, C. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.10.005 · Cited by 52
APOEgenotype-dependent modulation of astrocyte chemokine CCL3 production
Cudaback, E., Yang, Y. J., Montine, T. J., & Keene, C. D. (2014) · Glia · doi:10.1002/glia.22732 · Cited by 50
Takeuchi, D., Sato, N., Shimamura, M., Kurinami, H., Takeda, S., Shinohara, M., Suzuki, S., Kojima, M., Ogihara, T., & Morishita, R. (2008) · Gene Therapy · doi:10.1038/sj.gt.3303094 · Cited by 49
Serum amyloid A (SAA)-induced remodeling of CSF-HDL
Miida, T., Yamada, T., Seino, U., Ito, M., Fueki, Y., Takahashi, A., Kosuge, K., Soda, S., Hanyu, O., Obayashi, K., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2006.03.013 · Cited by 49
Park, K., Baik, H. H., & Jin, B. (2008) · Current Aging Science · doi:10.2174/1874609810801030192 · Cited by 49
Nuclear retention of IL‐1α by necrotic cells: A mechanism to dampen sterile inflammation
Luheshi, N., McColl, B. W., & Brough, D. (2009) · European Journal of Immunology · doi:10.1002/eji.200939712 · Cited by 49
Romanelli, M. M. C., Licastro, F., Porcellini, E., Dogliotti, G., Galliera, E., Lamont, J. L., Innocenzi, P. J., & Fitzgerald, S. P. (2011) · Biogerontology · doi:10.1007/s10522-011-9335-6 · Cited by 48
de Haas, C. J. C., van der Zee, R., Benaissa-Trouw, B. J., van Kessel, K. P. M., Verhoef, J., & van Strijp, J. A. G. (1999) · Infection and Immunity · doi:10.1128/iai.67.6.2790-2796.1999 · Cited by 47
Decreased Levels of Intrathecal Interleukin 1 Receptor Antagonist in Alzheimer’s Disease
Tarkowski, E., Liljeroth, A.-M., Nilsson, Å. L., Minthon, L., & Blennow, K. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051276 · Cited by 46
Alzheimer’s Disease and Genetics of Inflammation: A Pharmacogenomic Vision
Vasto, S., Candore, G., Duro, G., Lio, D., Grimaldi, M. P., & Caruso, C. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.12.1735 · Cited by 46
Yano, Y., Matsuda, S., Hatakeyama, K., Sato, Y. Z., Imamura, T., Shimada, K., Kodama, T., Kario, K., & Asada, Y. (2010) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq030 · Cited by 46
The role of soluble intercellular adhesion molecules in neurodegenerative disorders
Rentzos, M., Michalopoulou, M., Nikolaou, C., Cambouri, C., Rombos, A., Dimitrakopoulos, A., & Vassilopoulos, D. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.001 · Cited by 45
Astrocytes contain amyloid-β annular protofibrils in Alzheimer's disease brains
Lasagna‐Reeves, C. A., & Kayed, R. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.027 · Cited by 44
Laske, C., Stransky, E., Hoffmann, N., Maetzler, W., Straten, G., Eschweiler, G. W., & Leyhe, T. (2010) · Current Alzheimer Research · doi:10.2174/156720510791383813 · Cited by 44
Interleukin-Targeted Therapy for Metabolic Syndrome and Type 2 Diabetes
Maedler, K., Dharmadhikari, G., Schumann, D., & Størling, J. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_11 · Cited by 43
Hesske, L., Vincenzetti, C., Heikenwälder, M. F., Prinz, M., Reith, W., Fontana, A., & Suter, T. B. (2010) · Brain · doi:10.1093/brain/awq081 · Cited by 43
Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model
Wang, Q., Xu, Y., Chen, J., Qin, Y., Liu, M., Liu, Y., Xie, M.-J., Yu, Z., Zhu, Z., & Wang, W. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.011 · Cited by 42
Modulating Nitric Oxide Signaling in the Cns for Alzheimer’s Disease Therapy
Zhihui, Q. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.111 · Cited by 42
Lipoprotein‐associated phospholipase A2 is associated with risk of dementia
van Oijen, M., van der Meer, I. M., Albert Hofman, D., Witteman, J. C. M., Koudstaal, P. J., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20721 · Cited by 41
Yang, L., Lu, R., Jiang, L., Liu, Z., & Peng, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2008.10.019 · Cited by 41
Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study
Fitzpatrick, A. L., Irizarry, M. C., Cushman, M., Jenny, N. S., Chi, G. C., & Koro, C. E. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.04.032 · Cited by 41
Focal Inflammation in the Brain: Role in Alzheimer's Disease
Cooper, N. R., Bradt, B. M., O’Barr, S. A., & Yu, J. X. (2000) · Immunologic Research · doi:10.1385/ir:21:2-3:159 · Cited by 41
Bellucci, C., Lilli, C., Baroni, T., Parnetti, L., Sorbi, S., Emiliani, C., Lumare, E., Calabresi, P., Balloni, S., & Bodo, M. (2007) · Molecular Medicine · doi:10.2119/2007-00034.bellucci · Cited by 41
Neuroinflammation and Neurodegeneration
Morales, I., Farias, G. A., Cortés, N., & Maccioni, R. B. (2016) · InTech eBooks · doi:10.5772/64545 · Cited by 41
Expression of LIF and LIF receptor beta in Alzheimer’s and Parkinson’s diseases
Soilu‐Hänninen, M., Broberg, E., Röyttä, M., Mattila, P. M., Rinne, J. O., & Hukkanen, V. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2009.01179.x · Cited by 40
Endothelin-1 is Elevated in Alzheimer's Disease Brain Microvessels and is Neuroprotective
Luo, J., & Grammas, P. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091486 · Cited by 39
Cited by
The Lancet Commission on global mental health and sustainable development
Patel, V., Saxena, S., Lund, C., Thornicroft, G., Baingana, F., Bolton, P., Chisholm, D., Collins, P. Y., Cooper, J. L., Eaton, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31612-x · Cited by 3,692
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
Antibiotics, gut microbiota, and Alzheimer’s disease
Angelucci, F., Cechova, K., Amlerova, J., & Hort, J. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1494-4 · Cited by 454
The progress of gut microbiome research related to brain disorders
Zhu, S., Jiang, Y., Xu, K., Cui, M., Ye, W., Zhao, G., Jin, L., & Chen, X. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1705-z · Cited by 419
“coli, Salmonella spp, Pseudomonas fluorescens, Klebsiella pneumonia, Staphylococcus aureus, Bacillus subtills, Streptomyces coelicolor [190, 196, 197]; Chlamydia pneumoniae infection [199] Increased levels of IL-1beta, IL-6, and TNF-alpha [186, 187]; extracellular amyloids such as CsgA, Aβ42, FapC, MccE492, phenol-sol…”
BackgroundInfluential
Metadata
- Authors
- Bagyinszky, E., Giau, V. V., Shim, K., Suk, K., An, S. S. A., & Kim, S.
- Venue
- Journal of the Neurological Sciences
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 376
- Pages
- 242-254
- ISSN
- 0022-510X (ISSN-L)
- OpenAlex
- W2603205880
- Cited by
- 262
- References
- 243
- FWCI
- 14.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.